International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease

Journal of Inherited Metabolic Disease

Volumn 30, Issue 2, 2007, Pages 165-174

  Montano A M ^a   Tomatsu, S ^a   Gottesman, G S ^a   Smith, M ^b   Orii, T ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b International Morquio Organization   (United States)

^c GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DYSPLASIA; CLINICAL FEATURE; DISEASE COURSE; EAR; FAMILY HISTORY; FEMALE; HIP; HUMAN; INFANT; LEG; MAJOR CLINICAL STUDY; MALE; MORQUIO SYNDROME; NECK; ORTHOPEDIC SURGERY; PHENOTYPE; PHYSICAL ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; REGISTER; SYMPTOM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; INTERNATIONALITY; MALE; MEDICAL RECORDS; MIDDLE AGED; MOTOR ACTIVITY; MUCOPOLYSACCHARIDOSIS IV; PHENOTYPE; REGISTRIES;

EID: 33947615114     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0529-7     Document Type: Article

References (25)

1. Applegarth DA, Toone JR, Lowry RB (2000) Incidence of inborn errors of metabolism in British Columbia. Pediatrics 105: E10.
2. Dorfman A, Arbogast B, Matalon R (1976) The enzymic defects in Morquio and Maroteaux-Lamy syndrome. Adv Exp Med Biol 68: 261-276.
3. Fukuda S, Tomatsu S, Masue M, et al (1992) Mucopolysaccharidosis type IVA: N -acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases. J Clin Invest 90: 1049-1053.
4. Glossl J, Kresse H (1982) Impaired degradation of keratan sulphate by Morquio A fibroblasts. Biochem J 203: 335-338.
5. Hori T, Tomatsu S, Nakashima Y, et al (1995) Mucopolysaccharidosis type IVA: Common double deletion at the N -acetylgalactosamine-6-sulfate sulfatase gene. Genomics 26: 535-542.
6. Kato Z, Fukuda S, Tomatsu S, et al (1997) A novel common missense mutation G301C in the N -acetylgalactosamine-6-sulfate sulfatase gene in mucopolysaccharidosis IVA. Hum Genet 101: 97-101.
7. Lowry RB, Applegarth DA, Toone JR, et al (1990) An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 85: 389-390.
8. Meikle PJ, Hopwood JJ, Clague AE, et al (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249-254.
9. Montaño AM, Yamagishi A, Tomatsu S, et al (2000) The mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene: CDNA isolation, genomic characterization, chromosomal assignment and analysis of the 5′-flanking region. Biochim Biophys Acta 1500: 323-334.
10. Montaño AM, Kaitila I, Sukegawa K, et al (2003) Mucopolysaccharidosis IVA: Characterization of a common mutation found in Finnish patients with attenuated phenotype. Hum Genet 113: 162-169.
11. Morquio L (1929) Sur une forme de dystrophie osseuse familiale. Bull Soc Pediat Paris 27: 145-152.
12. Nakashima Y, Tomatsu S, Hori T, et al (1994) Mucopolysaccharidosis IVA: molecular cloning of the human N -acetylgalactosamine 6-sulfatase (GALNS) gene and analysis of the 5′-flanking region. Genomics 20: 99-104.
13. Nelson J (1997) Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 101: 355-358.
14. Northover H, Cowie RA, Wraith JE (1996) Mucopolysaccharidosis type IVA (Morquio syndrome): A clinical review. J Inherit Metab Dis 19: 357-365.
15. Ogawa T, Tomatsu S, Fukuda S, et al (1995) Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetyl galactosamine-6-sulfate sulfatase gene. Hum Mol Genet 4: 341-349.
16. Pinto R, Caseiro C, Lemos M, et al (2004) Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 12: 87-92.
17. Poorthuis BJ, Wevers RA, Kleijer WJ, et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105: 151-156.
18. Sukegawa K, Nakamura H, Kato Z, et al (2000) Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Mol Genet 22: 1283-1290.
19. Terzioglu M, Tokatli A, Coskun T, et al (2002) Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: Identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene. Hum Mutat 20: 477-478.
20. Tomatsu S, Fukuda S, Masue M, et al (1991) Morquio disease: Isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun 181: 677-683.
21. Tomatsu S, Orii KO, Vogler C, et al (2003) Mouse model of N -acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet 12: 3349-3358.
22. Tomatsu S, Montaño AM, Nishioka T, et al (2005a) Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 26: 500-512.
23. tm(hC79ṠmC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum Mol Genet 14: 3321-3335.
24. Winkel LPF, Hagemans MLC, van Doorn PA, et al (2005) The natural course of non-classical Pompe's disease; a review of 225 published cases. J Neurol 252: 875-884.
25. Yamada N, Fukuda S, Tomatsu S, et al (1998) Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype. Hum Mutat 11: 202-208.